Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

14th Oct 2014 17:34

RNS Number : 3150U
GlaxoSmithKline PLC
14 October 2014
 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors and Persons Discharging Managerial Responsibility (PDMR) on 14 October 2014 of the following increases in their notional interests in Ordinary Shares at a price of 1404.00 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $45.63 per ADS following the notional re-investment of the dividend paid to shareholders on 2 October 2014.

 

 

Director/PDMR

Ordinary Shares

ADSs

Sir Andrew Witty

18,700.225

Dr M M Slaoui

5,761.611

Mr S Dingemans

7,854.435

Mr R G Connor

2,568.688

Mrs D P Connelly

2,395.995

Mr J Ford

309.896

Mr S A Hussain

6,371.575

Mr W C Louv

1,690.149

Mr D S Redfern

2,704.765

Ms C Thomas

3,732.993

Mr P C Thomson

1,820.901

Mr D E Troy

3,424.225

Dr P J T Vallance

7,777.092

Ms E Walmsley

4,520.938

Mrs V A Whyte

517.597

 

 

 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

14 October 2014

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQZLFFZBFXFBL

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77